secwatch / observer
8-K filed June 21, 2022, 7:59 PM ET ticker KPRX CIK 0001372514
leadership confidence high sentiment neutral materiality 0.50

Interim CFO Susan L. Drexler resigns; CEO assumes principal financial officer role

KIORA PHARMACEUTICALS INC

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Brian M. Strem, Ph.D.

principal financial and accounting officer
KPRX · KIORA PHARMACEUTICALS INC
Effective
2022-06-16
Filed
June 21, 2022, 7:59 PM ET
Brian M. Strem, Ph.D., the Company’s President and Chief Executive Officer, will assume the role of the Company’s principal financial and accounting officer.
Departed

Susan L. Drexler

Interim Chief Financial Officer
KPRX · KIORA PHARMACEUTICALS INC
Effective
2022-06-16
Successor
Brian M. Strem, Ph.D.
Filed
June 21, 2022, 7:59 PM ET
Effective as of June 16, 2022, Ms. Drexler resigned as Interim Chief Financial Officer of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian M. Strem, Ph.D. changed role as principal financial and accounting officer at KIORA PHARMACEUTICALS INC.

Action
assumed
Role
principal financial and accounting officer
Exact text from the filing
Brian M. Strem, Ph.D., the Company’s President and Chief Executive Officer, will assume the role of the Company’s principal financial and accounting officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Susan L. Drexler resigned as Interim Chief Financial Officer at KIORA PHARMACEUTICALS INC.

Action
resigned
Role
Interim Chief Financial Officer
Exact text from the filing
Effective as of June 16, 2022, Ms. Drexler resigned as Interim Chief Financial Officer of the Company
View on SEC.gov

KIORA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR
accession 0001104659-22-073063
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.